News from chimerix, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Mar 28, 2013, 07:00 ET

Chimerix's Antiviral CMX001 Abstract Selected for an Oral Presentation at the European Group for Blood and Marrow Transplantation's Annual Meeting

Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced presentations...

Mar 14, 2013, 07:00 ET

Chimerix Appoints Michael D. Rogers, Ph.D., as Chief Development Officer

 Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, announced today that...

Mar 12, 2013, 07:00 ET

FDA Grants Chimerix Fast Track Designation for CMX001 for the Prevention of Clinically Significant Cytomegalovirus Infection

 Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that the...

Mar 08, 2013, 17:10 ET

Chimerix Files Registration Statement for Proposed Initial Public Offering

Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it has...

Feb 20, 2013, 07:00 ET

Ernest Mario, Ph.D., Named Chairman of Chimerix, Inc.

Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the appointment...

Feb 19, 2013, 07:00 ET

Data Demonstrating the Safety and Efficacy of Chimerix's Antiviral CMX001 Presented at BMT Tandem Meetings

 Chimerix, Inc., a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today released data from...

Feb 04, 2013, 07:00 ET

Data Related to Chimerix's Antiviral CMX001 to be Presented in Three Poster Sessions at the BMT Tandem Meetings

 Chimerix, Inc., a biopharmaceutical company developing antivirals in areas of high unmet medical need, today announced that three abstracts...

Nov 26, 2012, 07:00 ET

Chimerix To Present At Therapeutic Area Partnerships Meeting

 Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced that President and Chief Executive...

Nov 12, 2012, 09:00 ET

Chimerix Appoints Michelle Berrey Chief Medical Officer

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, announced today that Michelle Berrey, MD, MPH, has...

Nov 12, 2012, 07:00 ET

Chimerix To Present At Two Upcoming Healthcare Conferences In November

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced presentations at two upcoming investor...

Sep 21, 2012, 12:56 ET

Chimerix Presents Data Highlighting Burden Of Care Associated With Current Antiviral Therapies In Stem Cell Transplantation

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced data highlighting the significant...

Jul 24, 2012, 07:30 ET

Chimerix Signs Worldwide License Agreement With Merck For CMX157, A Novel Candidate For The Treatment Of HIV

 Chimerix, Inc. today announced the execution of a license agreement granting Merck, known as MSD outside the United States and Canada,...

Jul 23, 2012, 10:37 ET

Chimerix's Broad Spectrum Antiviral Therapeutic, CMX001, Demonstrates Potential To Mitigate BK Virus Associated End-Organ Disease In Clinical Study

 Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced the presentation of data showing...

Jul 09, 2012, 10:00 ET

Chimerix Announces BK Virus Data In Late-Breaking Poster Session At The 24th International Congress Of The Transplantation Society

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced a late-breaking poster presentation at...

Apr 03, 2012, 10:00 ET

Chimerix to Present at Upcoming Needham and Future Leaders Conferences

Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced presentations at two upcoming investor conferences...

Mar 05, 2012, 10:00 ET

Chimerix to Present at Cowen and Company's 32nd Annual Health Care Conference

 Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced that Kenneth I. Moch, President and Chief...

Feb 06, 2012, 08:30 ET

Chimerix Antiviral Compound, CMX001, Meets CMV Phase 2 Primary Endpoint in Allogeneic Hematopoietic Stem Cell Transplant Recipients

 Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced positive results from CMX001 Study 201, a...

Jan 25, 2012, 12:00 ET

Chimerix Announces Presentation of Final Data from CMX001 Phase 2 Trial in Prophylaxis of Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients

Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced that final data from CMX001 Study 201, a...

Nov 11, 2011, 12:06 ET

Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced a late-breaking poster presentation at...

Nov 09, 2011, 10:00 ET

Chimerix to Present at Upcoming Lazard and Piper Jaffray Healthcare Conferences

Chimerix, Inc., a biotechnology company developing orally-available antiviral therapeutics, today announced that Kenneth I. Moch, President and...